Samantha Goodman1, Elle Wadsworth2, Cesar Leos-Toro3, David Hammond4. 1. School of Public Health and Health Systems, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Electronic address: samantha.goodman@uwaterloo.ca. 2. School of Public Health and Health Systems, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Electronic address: ewadsworth@uwaterloo.ca. 3. School of Public Health and Health Systems, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Electronic address: cleostor@uwaterloo.ca. 4. School of Public Health and Health Systems, University of Waterloo, Waterloo, ON N2L 3G1, Canada. Electronic address: dhammond@uwaterloo.ca.
Abstract
BACKGROUND: Recreational or 'non-medical cannabis' has been legalized in several US states, and was legalized federally in Canada in October 2018. There is little comparative data on product use across jurisdictions, particularly with respect to the types of cannabis products used, which differentially impact health. METHODS: Data are from Wave 1 of the International Cannabis Policy Study, collected from Aug 27-Oct 7, 2018. Respondents (n = 27,024) aged 16-65 completed an online survey measuring patterns of cannabis use, quantities and routes of administration. Respondents were recruited from Canada (n = 9976) and US states that had (n = 7362) and had not (n = 9686) legalized non-medical cannabis ('legal' and 'illegal' states, respectively). RESULTS: Prevalence of at least daily, weekly, and monthly cannabis use were significantly higher in US 'legal' states (11.3%, 18.2%, 25.0%, respectively) than US 'illegal' states (7.4%, 11.6%, 16.8%, respectively; p<0.001) and Canada (8.9%, 14.1%, 19.0%, respectively; p ≤ 0.01). Dried herb was the dominant form of cannabis reported by past 12-month users across all jurisdictions (77.7%-80.8%). Although the amount of dried herb used per year did not differ by jurisdiction (range: 210.3-229.4 g), those in US 'legal' states were significantly more likely to use dried herb daily or weekly than were those in 'illegal' states and Canada (p<0.001). Use of cannabis concentrates, vaped oils, edibles, and drinks was more prevalent among US 'legal' states than 'illegal' states and Canada (p ≤ 0.001). Vaping dried herb was more common in both legal and illegal US jurisdictions than in Canada (p<0.05), whereas Canadians were more likely to smoke dried herb with tobacco (p<0.001). CONCLUSION: The prevalence of cannabis use-and use of products such as cannabis concentrates, edibles and drinks-was higher in US states that had legalized cannabis. Additional longitudinal research is required to determine whether these differences reflect causal effects of legalization or pre-existing secular trends.
BACKGROUND: Recreational or 'non-medical cannabis' has been legalized in several US states, and was legalized federally in Canada in October 2018. There is little comparative data on product use across jurisdictions, particularly with respect to the types of cannabis products used, which differentially impact health. METHODS: Data are from Wave 1 of the International Cannabis Policy Study, collected from Aug 27-Oct 7, 2018. Respondents (n = 27,024) aged 16-65 completed an online survey measuring patterns of cannabis use, quantities and routes of administration. Respondents were recruited from Canada (n = 9976) and US states that had (n = 7362) and had not (n = 9686) legalized non-medical cannabis ('legal' and 'illegal' states, respectively). RESULTS: Prevalence of at least daily, weekly, and monthly cannabis use were significantly higher in US 'legal' states (11.3%, 18.2%, 25.0%, respectively) than US 'illegal' states (7.4%, 11.6%, 16.8%, respectively; p<0.001) and Canada (8.9%, 14.1%, 19.0%, respectively; p ≤ 0.01). Dried herb was the dominant form of cannabis reported by past 12-month users across all jurisdictions (77.7%-80.8%). Although the amount of dried herb used per year did not differ by jurisdiction (range: 210.3-229.4 g), those in US 'legal' states were significantly more likely to use dried herb daily or weekly than were those in 'illegal' states and Canada (p<0.001). Use of cannabis concentrates, vaped oils, edibles, and drinks was more prevalent among US 'legal' states than 'illegal' states and Canada (p ≤ 0.001). Vaping dried herb was more common in both legal and illegal US jurisdictions than in Canada (p<0.05), whereas Canadians were more likely to smoke dried herb with tobacco (p<0.001). CONCLUSION: The prevalence of cannabis use-and use of products such as cannabis concentrates, edibles and drinks-was higher in US states that had legalized cannabis. Additional longitudinal research is required to determine whether these differences reflect causal effects of legalization or pre-existing secular trends.
Authors: Taylor Lensch; Kim Sloan; Julia Ausmus; Jennifer L Pearson; Kristen Clements-Nolle; Samantha Goodman; David Hammond Journal: Prev Med Date: 2020-11-05 Impact factor: 4.018
Authors: Shannon Gravely; Pete Driezen; Danielle M Smith; Ron Borland; Eric N Lindblom; David Hammond; Ann McNeill; Andrew Hyland; K Michael Cummings; Gary Chan; Mary E Thompson; Christian Boudreau; Nadia Martin; Janine Ouimet; Ruth Loewen; Anne C K Quah; Maciej L Goniewicz; James F Thrasher; Geoffrey T Fong Journal: Int J Drug Policy Date: 2020-04-16
Authors: Theresa E Matson; Gwen T Lapham; Jennifer F Bobb; Eric Johnson; Julie E Richards; Amy K Lee; Katharine A Bradley; Joseph E Glass Journal: Drug Alcohol Depend Date: 2020-08-08 Impact factor: 4.492
Authors: Catherine F Moore; Catherine M Davis; Eric L Harvey; Michael A Taffe; Elise M Weerts Journal: Pharmacol Biochem Behav Date: 2021-01-23 Impact factor: 3.533
Authors: Elizabeth A Evans; Eva Goldwater; Edward J Stanek; Penny Brierley-Bowers; David Buchanan; Jennifer M Whitehill Journal: J Psychoactive Drugs Date: 2020-11-26